Which has higher earnings & valuation, HTFL or HIMS?

Hims & Hers Health has higher revenue and earnings than Heartflow. Hims & Hers Health is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 17.30 -$116.79M -$3.11 N/A Hims & Hers Health $2.35B 3.34 $128.37M -$0.09 N/A

Which has higher earnings & valuation, HTFL or PACS?

PACS Group has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 17.30 -$116.79M -$3.11 N/A PACS Group $5.29B 1.23 $191.54M $1.56 26.38

Is HTFL or PACS more profitable?

PACS Group has a net margin of 4.49% compared to Heartflow's net margin of -58.42%. PACS Group's return on equity of 26.47% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -58.42% N/A -20.02% PACS Group 4.49% 26.47% 4.36%

Which has higher valuation & earnings, CAI or HTFL?

Caris Life Sciences has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Caris Life Sciences $348.89M 15.59 -$68.09M -$7.61 N/A Heartflow $176.03M 17.30 -$116.79M -$3.11 N/A

Which has stronger valuation & earnings, BLLN or HTFL?

Billiontoone has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Billiontoone $354.54M 15.17 $7.45M $0.55 212.55 Heartflow $176.03M 17.30 -$116.79M -$3.11 N/A

Is BLLN or HTFL more profitable?

Billiontoone has a net margin of 0.00% compared to Heartflow's net margin of -58.42%. Company Net Margins Return on Equity Return on Assets Billiontoone N/A N/A N/A Heartflow -58.42% N/A -20.02%

Which has preferable earnings and valuation, HTFL or SHC?

Sotera Health has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 17.30 -$116.79M -$3.11 N/A Sotera Health $1.16B 4.23 $77.94M $0.41 42.06

Heartflow (HTFL) Competitors

$35.32 +0.34 (+0.97%)

As of 02:21 PM Eastern

Compare

HTFL vs. HIMS, PACS, CAI, BLLN, and SHC

Should you buy Heartflow stock or one of its competitors? MarketBeat compares Heartflow with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Heartflow include Hims & Hers Health (HIMS), PACS Group (PACS), Caris Life Sciences (CAI), Billiontoone (BLLN), and Sotera Health (SHC). These companies are all part of the "healthcare" industry.

How does Heartflow compare to Hims & Hers Health?

Heartflow (NASDAQ:HTFL) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

Heartflow presently has a consensus price target of $37.00, suggesting a potential upside of 4.75%. Hims & Hers Health has a consensus price target of $29.37, suggesting a potential downside of 13.30%. Given Heartflow's stronger consensus rating and higher possible upside, equities analysts clearly believe Heartflow is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13

Hims & Hers Health has higher revenue and earnings than Heartflow. Hims & Hers Health is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	17.30	-$116.79M	-$3.11	N/A
Hims & Hers Health	$2.35B	3.34	$128.37M	-$0.09	N/A

63.5% of Hims & Hers Health shares are held by institutional investors. 7.7% of Heartflow shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Hims & Hers Health has a net margin of -0.56% compared to Heartflow's net margin of -58.42%. Hims & Hers Health's return on equity of 6.10% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-58.42%	N/A	-20.02%
Hims & Hers Health	-0.56%	6.10%	1.52%

In the previous week, Hims & Hers Health had 19 more articles in the media than Heartflow. MarketBeat recorded 20 mentions for Hims & Hers Health and 1 mentions for Heartflow. Heartflow's average media sentiment score of 1.89 beat Hims & Hers Health's score of 0.58 indicating that Heartflow is being referred to more favorably in the media.

Company	Overall Sentiment
Heartflow	Very Positive
Hims & Hers Health	Positive

Summary

Hims & Hers Health beats Heartflow on 9 of the 15 factors compared between the two stocks.

How does Heartflow compare to PACS Group?

Heartflow (NASDAQ:HTFL) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

PACS Group has a net margin of 4.49% compared to Heartflow's net margin of -58.42%. PACS Group's return on equity of 26.47% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-58.42%	N/A	-20.02%
PACS Group	4.49%	26.47%	4.36%

In the previous week, PACS Group had 8 more articles in the media than Heartflow. MarketBeat recorded 9 mentions for PACS Group and 1 mentions for Heartflow. Heartflow's average media sentiment score of 1.89 beat PACS Group's score of 0.39 indicating that Heartflow is being referred to more favorably in the media.

Company	Overall Sentiment
Heartflow	Very Positive
PACS Group	Neutral

PACS Group has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	17.30	-$116.79M	-$3.11	N/A
PACS Group	$5.29B	1.23	$191.54M	$1.56	26.38

Heartflow currently has a consensus price target of $37.00, suggesting a potential upside of 4.75%. PACS Group has a consensus price target of $48.00, suggesting a potential upside of 16.62%. Given PACS Group's stronger consensus rating and higher possible upside, analysts plainly believe PACS Group is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Summary

PACS Group beats Heartflow on 10 of the 13 factors compared between the two stocks.

How does Heartflow compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

Caris Life Sciences has a net margin of 3.75% compared to Heartflow's net margin of -58.42%. Caris Life Sciences' return on equity of 98.28% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
Heartflow	-58.42%	N/A	-20.02%

In the previous week, Caris Life Sciences had 1 more articles in the media than Heartflow. MarketBeat recorded 2 mentions for Caris Life Sciences and 1 mentions for Heartflow. Heartflow's average media sentiment score of 1.89 beat Caris Life Sciences' score of 1.42 indicating that Heartflow is being referred to more favorably in the news media.

Company	Overall Sentiment
Caris Life Sciences	Positive
Heartflow	Very Positive

Caris Life Sciences presently has a consensus target price of $27.56, indicating a potential upside of 43.18%. Heartflow has a consensus target price of $37.00, indicating a potential upside of 4.75%. Given Caris Life Sciences' higher probable upside, equities research analysts plainly believe Caris Life Sciences is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

Caris Life Sciences has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$348.89M	15.59	-$68.09M	-$7.61	N/A
Heartflow	$176.03M	17.30	-$116.79M	-$3.11	N/A

Summary

Caris Life Sciences beats Heartflow on 8 of the 12 factors compared between the two stocks.

How does Heartflow compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk, analyst recommendations and media sentiment.

Billiontoone has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$354.54M	15.17	$7.45M	$0.55	212.55
Heartflow	$176.03M	17.30	-$116.79M	-$3.11	N/A

Billiontoone has a net margin of 0.00% compared to Heartflow's net margin of -58.42%.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Heartflow	-58.42%	N/A	-20.02%

In the previous week, Billiontoone had 2 more articles in the media than Heartflow. MarketBeat recorded 3 mentions for Billiontoone and 1 mentions for Heartflow. Heartflow's average media sentiment score of 1.89 beat Billiontoone's score of 0.96 indicating that Heartflow is being referred to more favorably in the news media.

Company	Overall Sentiment
Billiontoone	Positive
Heartflow	Very Positive

Billiontoone currently has a consensus price target of $125.29, indicating a potential upside of 7.17%. Heartflow has a consensus price target of $37.00, indicating a potential upside of 4.75%. Given Billiontoone's higher probable upside, analysts plainly believe Billiontoone is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

Summary

Billiontoone beats Heartflow on 8 of the 11 factors compared between the two stocks.

How does Heartflow compare to Sotera Health?

Heartflow (NASDAQ:HTFL) and Sotera Health (NASDAQ:SHC) are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

In the previous week, Sotera Health had 1 more articles in the media than Heartflow. MarketBeat recorded 2 mentions for Sotera Health and 1 mentions for Heartflow. Heartflow's average media sentiment score of 1.89 beat Sotera Health's score of 1.87 indicating that Heartflow is being referred to more favorably in the media.

Company	Overall Sentiment
Heartflow	Very Positive
Sotera Health	Very Positive

Sotera Health has a net margin of 9.91% compared to Heartflow's net margin of -58.42%. Sotera Health's return on equity of 39.73% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-58.42%	N/A	-20.02%
Sotera Health	9.91%	39.73%	7.05%

91.0% of Sotera Health shares are owned by institutional investors. 7.7% of Heartflow shares are owned by insiders. Comparatively, 15.4% of Sotera Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Heartflow currently has a consensus price target of $37.00, indicating a potential upside of 4.75%. Sotera Health has a consensus price target of $20.25, indicating a potential upside of 17.43%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts plainly believe Sotera Health is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Sotera Health has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	17.30	-$116.79M	-$3.11	N/A
Sotera Health	$1.16B	4.23	$77.94M	$0.41	42.06

Summary

Sotera Health beats Heartflow on 13 of the 15 factors compared between the two stocks.

Get Heartflow News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HTFL vs. The Competition

Export

Metric	Heartflow	Health Information Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.04B	$360.19M	$6.79B	$12.22B
Dividend Yield	N/A	5.61%	2.68%	5.90%
P/E Ratio	-11.34	254.91	25.68	24.07
Price / Sales	17.30	130.77	554.75	99.97
Price / Cash	N/A	47.14	46.33	53.91
Price / Book	10.01	7.24	10.70	6.33
Net Income	-$116.79M	-$22.78M	$3.57B	$337.69M
7 Day Performance	5.00%	0.39%	2.38%	-0.71%
1 Month Performance	24.37%	1.27%	1.56%	-0.10%
1 Year Performance	N/A	-9.94%	31.69%	26.23%

Heartflow Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HTFL Heartflow	1.7917 of 5 stars	$35.32 +1.0%	$37.00 +4.8%	N/A	$3.04B	$176.03M	N/A	699
HIMS Hims & Hers Health	2.4851 of 5 stars	$32.78 +0.2%	$29.37 -10.4%	-20.8%	$7.59B	$2.35B	N/A	2,442	Trending News Insider Trade Gap Down
PACS PACS Group	3.7011 of 5 stars	$40.49 +4.2%	$48.00 +18.6%	+215.3%	$6.41B	$5.29B	25.95	47,455	News Coverage Analyst Forecast
CAI Caris Life Sciences	4.1705 of 5 stars	$18.70 +3.0%	$27.56 +47.4%	N/A	$5.29B	$812.03M	N/A	1,846	Positive News
BLLN Billiontoone	2.9486 of 5 stars	$112.24 +4.2%	$125.29 +11.6%	N/A	$5.16B	$305.11M	204.07	620	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HTFL) was last updated on 6/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Heartflow (HTFL) Competitors

HTFL vs. HIMS, PACS, CAI, BLLN, and SHC

How does Heartflow compare to Hims & Hers Health?

Summary

How does Heartflow compare to PACS Group?

Summary

How does Heartflow compare to Caris Life Sciences?

Summary

How does Heartflow compare to Billiontoone?

Summary

How does Heartflow compare to Sotera Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HTFL vs. The Competition

Heartflow Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Heartflow (HTFL) Competitors

HTFL vs. HIMS, PACS, CAI, BLLN, and SHC

How does Heartflow compare to Hims & Hers Health?

Do analysts recommend HTFL or HIMS?

Which has higher earnings & valuation, HTFL or HIMS?

Do insiders & institutionals believe in HTFL or HIMS?

Is HTFL or HIMS more profitable?

Does the media prefer HTFL or HIMS?

Summary

How does Heartflow compare to PACS Group?

Is HTFL or PACS more profitable?

Does the media refer more to HTFL or PACS?

Which has higher earnings & valuation, HTFL or PACS?

Do analysts rate HTFL or PACS?

Summary

How does Heartflow compare to Caris Life Sciences?

Is CAI or HTFL more profitable?

Does the media prefer CAI or HTFL?

Do analysts recommend CAI or HTFL?

Which has higher valuation & earnings, CAI or HTFL?

Summary

How does Heartflow compare to Billiontoone?

Which has stronger valuation & earnings, BLLN or HTFL?

Is BLLN or HTFL more profitable?

Does the media favor BLLN or HTFL?

Do analysts recommend BLLN or HTFL?

Summary

How does Heartflow compare to Sotera Health?

Does the media favor HTFL or SHC?

Is HTFL or SHC more profitable?

Do institutionals & insiders believe in HTFL or SHC?

Do analysts rate HTFL or SHC?

Which has preferable earnings and valuation, HTFL or SHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HTFL vs. The Competition

Heartflow Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools